Effect of low extracellular pH on NF-κB activation in macrophages

Atherosclerosis. 2014 Apr;233(2):537-544. doi: 10.1016/j.atherosclerosis.2014.01.014. Epub 2014 Jan 21.

Abstract

Objective: Many diseases, including atherosclerosis, involve chronic inflammation. The master transcription factor for inflammation is NF-κB. Inflammatory sites have a low extracellular pH. Our objective was to demonstrate the effect of pH on NF-κB activation and cytokine secretion.

Methods: Mouse J774 macrophages or human THP-1 or monocyte-derived macrophages were incubated at pH 7.0-7.4 and inflammatory cytokine secretion and NF-κB activity were measured.

Results: A pH of 7.0 greatly decreased pro-inflammatory cytokine secretion (TNF or IL-6) by J774 macrophages, but not THP-1 or human monocyte-derived macrophages. Upon stimulation of mouse macrophages, the levels of IκBα, which inhibits NF-κB, fell but low pH prevented its later increase, which normally restores the baseline activity of NF-κB, even though the levels of mRNA for IκBα were increased. pH 7.0 greatly increased and prolonged NF-κB binding to its consensus promoter sequence, especially the anti-inflammatory p50:p50 homodimers. Human p50 was overexpressed using adenovirus in THP-1 macrophages and monocyte-derived macrophages to see if it would confer pH sensitivity to NF-κB activity in human cells. Overexpression of p50 increased p50:p50 DNA-binding and in THP-1 macrophages inhibited considerably TNF and IL-6 secretion, but there was still no effect of pH on p50:p50 DNA binding or cytokine secretion.

Conclusion: A modest decrease in pH can sometimes have marked effects on NF-κB activation and cytokine secretion and might be one reason to explain why mice normally develop less atherosclerosis than do humans.

Keywords: Atherosclerosis; Cytokines; Inflammation; Low pH; Macrophages; NF-κB; p50 Homodimers.

Publication types

  • Comparative Study
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Atherosclerosis / metabolism
  • Cell Line
  • Cells, Cultured
  • Consensus Sequence
  • DNA / metabolism
  • Disease Susceptibility
  • Extracellular Fluid / physiology*
  • Humans
  • Hydrogen-Ion Concentration*
  • I-kappa B Proteins / genetics
  • I-kappa B Proteins / metabolism
  • Interleukin-6 / metabolism
  • Macrophages / metabolism*
  • Mice
  • Monocytes / metabolism*
  • NF-KappaB Inhibitor alpha
  • NF-kappa B / metabolism*
  • NF-kappa B p50 Subunit / genetics
  • NF-kappa B p50 Subunit / metabolism
  • Promoter Regions, Genetic
  • Protein Binding
  • Recombinant Fusion Proteins / genetics
  • Recombinant Fusion Proteins / metabolism
  • Species Specificity
  • Tumor Necrosis Factor-alpha / metabolism

Substances

  • I-kappa B Proteins
  • IL6 protein, human
  • Interleukin-6
  • NF-kappa B
  • NF-kappa B p50 Subunit
  • NFKBIA protein, human
  • Nfkbia protein, mouse
  • Recombinant Fusion Proteins
  • Tumor Necrosis Factor-alpha
  • interleukin-6, mouse
  • NF-KappaB Inhibitor alpha
  • DNA